首页> 美国卫生研究院文献>Cardiovascular Ultrasound >The potential clinical value of contrast-enhanced echocardiography beyond current recommendations
【2h】

The potential clinical value of contrast-enhanced echocardiography beyond current recommendations

机译:超声心动图增强造影的潜在临床价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundContrast agents are used in resting echocardiography to opacify the left ventricular (LV) cavity and to improve LV endocardial border delineation in patients with suboptimal image quality. If a wider use of contrast-enhanced echocardiography would be adopted instead of the current selective approach, diagnoses such as myocardial ischemia and LV structural abnormalities could potentially be detected earlier. The aim was therefore to retrospectively investigate if contrast-enhanced echocardiography beyond the current recommendations for contrast agent usage affects assessment of wall motion abnormalities, ejection fraction (EF) and detection of LV structural abnormalities. A secondary aim was to evaluate the user dependency during image analysis.
机译:背景技术造影剂用于静息超声心动图检查中,可在图像质量欠佳的患者中使左心室(LV)腔不透明,并改善左心内膜边界。如果将广泛使用造影剂增强型超声心动图代替当前的选择方法,则可能会更早地检测出心肌缺血和左室结构异常等诊断。因此,本研究的目的是回顾性研究超声造影剂是否超出了当前使用造影剂的建议,是否会影响壁运动异常,射血分数(EF)和左室结构异常的检测。第二个目的是评估图像分析期间的用户依赖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号